Self Managed Care for Heart Disease
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research suggests that self-management can improve disease outcomes and quality of life for patients with cardiovascular disease, indicating that self-managed care may be beneficial for heart disease patients.
12345The research articles reviewed do not provide specific safety data for Self Managed Care for Heart Disease or its related terms. They focus on educational resources, self-care behaviors, and self-help groups for heart disease patients, but do not address safety concerns directly.
12467The self-managed care treatment for heart disease is unique because it empowers patients to actively participate in their own care, focusing on self-management strategies rather than relying solely on healthcare providers. This approach is designed to improve well-being and manage symptoms by fostering patient engagement and utilizing new modes of delivery for greater access to information.
4891011Eligibility Criteria
This trial is for English-speaking adults aged 18-70 who are undergoing a sternotomy, which is a type of heart surgery. They must be able to walk on their own. People with previous sternotomies, those getting VAD implants or cardiac transplants, or discharged over 1.5 weeks after surgery can't join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into two groups to receive either self-managed or standard sternal precautions post-surgery
Follow-up
Participants are monitored for postoperative outcomes, pain, and quality of life for up to a year